Clayton Dubilier & Rice

Clayton, Dubilier & Rice is a New York-based private equity firm with a long-standing reputation for operationally intensive investing, frequently using former operating CEOs as advisors and partners. Within healthcare, the firm focuses on building large-scale care delivery and tech-enabled services businesses. AI is not stated as a focus. CD&R typically pursues control buyouts and corporate carve-outs rather than minority growth investments.

Check sizes are $25M and above, with most deals well into the hundreds of millions. Deployment is concentrated in the United States and Europe. Specific portfolio companies in the healthcare AI segment are not provided in the source data.

For healthcare AI founders, CD&R is not a relevant near-term investor. The fit is a scaled services platform, often one being carved out of a strategic, with operational levers an experienced PE operator can pull. Founders below substantial revenue scale should not pitch. The realistic touch point is at a banker-led process or via portfolio-company strategy.